esc semaglutide SELECT: Semaglutide's Impact on CVD Events Emerges Quickly Oral Semaglutide Gets FDA Approval

by Summer Kessel, RD, CSOWM, LDN Spring 2025 If youre using a GLP-1 medication for obesity treatment, youve probably noticed changes in your appetite, digestion and even how you think about food

Comprehensive assessments included body weight, 2-D echocardiography, invasive hemodynamics, exercise capacity as well as cardiac and hepatic fibrosis and lipid deposition

Get workout, nutrition, and lifestyle guidance tailored to your needs.

weird skin sensations (?) I've been asked a lot about "microdosing"--what about "macrodosing?" In the recent STEP UP trial (n=1,407

Because Noveltreat introduces a new active peptide to your receptors, minor gastrointestinal adjustments can briefly appear as your metabolism recalibrates during the first few weeks